GREEN PLAINS INC
GPRENASDAQ🏆 #2449 by market capEarnings Oct 29 · PreUS Equity
$14.71▼ $0.09 (−0.61%)
🌙 After hours$14.50▼ 1.43%Regular close · extended-hours price shownTrack GPRE
Get earnings, price moves & breaking news on Telegram
24h▼ 0.6%
7d▼ 2.6%
14d▼ 2.4%
30d▲ 1.7%
ytd▲ 49.7%
1y▲ 67.5%
🏦Market Cap
$1.03B
Small Cap
📈Revenue Growth (YoY)
-14.9%
Declining
📊Gross Margin
10.0%
Thin
💵FCF Margin
6.4%
Moderate
⚖️P/S Ratio
0.6x
Cheap
Otter Score
60
Fair
GREEN PLAINS INC
GPREAnalyst Ratings
Price
$14.71
Total
20
Raised
3
Lowered
4
Avg PT
$20.00
H / L
$20 / $20
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
UBS | Reiterated | Neutral | 2026-07-17 | $20.00 | +36.00% |
Stephens & Co. | Reiterated | Overweight | 2026-05-08 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-04-22 | $20.00 | +36.00% |
BMO Capital | Reiterated | Market Perform | 2026-03-25 | $14.00 | −4.80% |
Roth Capital | Downgraded | Buy → Neutral | 2025-11-06 | $10.00 | −32.00% |
B of A Securities | Reiterated | Underperform | 2025-10-14 | — | — |
Jefferies | Downgraded | Buy → Hold | 2025-03-11 | $6.00 | −59.20% |
Truist Securities | Reiterated | Buy | 2025-02-13 | — | — |
Craig-Hallum | Reiterated | Buy | 2024-08-07 | — | — |
Roth MKM | Reiterated | Buy | 2024-05-06 | — | — |
Goldman Sachs | Reiterated | Buy | 2024-01-30 | — | — |
Evercore ISI Group | Upgraded | In Line → Outperform | 2022-01-18 | — | — |
Credit Suisse | Reiterated | Outperform | 2021-11-08 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2017-11-05 | — | — |
Piper Sandler | Upgraded | Neutral → Overweight | 2017-11-03 | — | — |
BB&T Capital | Reiterated | Buy | 2015-11-19 | — | — |
Vertical Research | Reiterated | Buy | 2015-07-07 | — | — |
Feltl & Co. | Downgraded | Buy → Hold | 2015-02-03 | — | — |
Imperial Capital | Reiterated | Outperform | 2014-03-31 | — | — |
Wedbush | Downgraded | Outperform → Neutral | 2014-02-07 | — | — |
Institution
UBS
Reiterated · Neutral · 2026-07-17
$20.00
+36.00%
Stephens & Co.
Reiterated · Overweight · 2026-05-08
—
—
Oppenheimer
Reiterated · Outperform · 2026-04-22
$20.00
+36.00%
BMO Capital
Reiterated · Market Perform · 2026-03-25
$14.00
−4.80%
Roth Capital
Downgraded · Buy → Neutral · 2025-11-06
$10.00
−32.00%
B of A Securities
Reiterated · Underperform · 2025-10-14
—
—
Jefferies
Downgraded · Buy → Hold · 2025-03-11
$6.00
−59.20%
Truist Securities
Reiterated · Buy · 2025-02-13
—
—
Craig-Hallum
Reiterated · Buy · 2024-08-07
—
—
Roth MKM
Reiterated · Buy · 2024-05-06
—
—
Goldman Sachs
Reiterated · Buy · 2024-01-30
—
—
Evercore ISI Group
Upgraded · In Line → Outperform · 2022-01-18
—
—
Credit Suisse
Reiterated · Outperform · 2021-11-08
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2017-11-05
—
—
Piper Sandler
Upgraded · Neutral → Overweight · 2017-11-03
—
—
BB&T Capital
Reiterated · Buy · 2015-11-19
—
—
Vertical Research
Reiterated · Buy · 2015-07-07
—
—
Feltl & Co.
Downgraded · Buy → Hold · 2015-02-03
—
—
Imperial Capital
Reiterated · Outperform · 2014-03-31
—
—
Wedbush
Downgraded · Outperform → Neutral · 2014-02-07
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space